2-(3-Chlorothiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

2-(3-Bromophenyl)-5-methyl-1,3,4-oxadiazole, 95.0%, 1g

2-Chloro-6-methylbenzoic acid, 98.0%, 100g

1,2-BIS((2R,5R)-2,5-DIPHENYLPHOSPHOLAN-1-YL)ETHANE, 95%, 50mg

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

{1-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]ethyl}amine trifluoroacetate, 95.0%, 25g

Fmoc-N4-Boc- L-2,4-diaminobutyric acid, 97.0%, 5g

Barium Nitrate 99.8 +% Extra pure 2.5 Kilogram

(3-Bromo-2,2-dimethylpropoxy)(tert-butyl)diphenylsilane, 98%, 25g

trans,trans-4'-Pentylbicyclohexyl-4-carboxylic Acid>98.0%(GC)5g

GC capillary column ROTI®Cap-WAX, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(4-Chloropyridin-3-yl)methanol hydrochloride, 95.0%, 10g

O-(4-Nitrobenzoyl)hydroxylamine, 95.0%, 5g